Skip to main content
OpenTrials

Clinical trial condition

Astrocytoma

Explore clinical trials studying Astrocytoma. Study availability and eligibility vary by location and protocol.

1,161 public trials 259 recruiting studies
Refine in advanced search Browse all conditions

Astrocytoma trial results

Recruiting

Anti-GD2 ADC M3554 in Advanced Solid Tumors

NCT06641908

Conditions
Advanced Solid Tumor, Astrocytoma, Glioblastoma, +10 more
Locations
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Memorial Sloan-Kettering Cancer Center (MSKCC) - New York - Memorial Sloan Kettering Cancer Center (CC)- Westc New York, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • UZ Leuven Leuven, Belgium
View Trial Details
Recruiting

Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM

NCT05902169

Conditions
Astrocytoma, GBM, Glioblastoma, +9 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • University of California, San Francisco San Francisco, California, United States
  • UCHealth Aurora, Colorado, United States
  • Mayo Clinic of Jacksonville Florida Jacksonville, Florida, United States
View all 55 locations
View Trial Details
Recruiting

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

NCT04094610

Conditions
Astrocytoma, Glioblastoma, Glioma, +30 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • University of California at Los Angeles Los Angeles, California, United States
  • Children's Hospital Colorado - Anschutz Medical Campus Aurora, Colorado, United States
  • Local Institution - 2105 Orlando, Florida, United States
View all 68 locations
View Trial Details
Recruiting

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

NCT07326566

Conditions
Astrocytoma, Brain Cancer, Brain Diseases, +19 more
Locations
  • University of Alabama at Birmingham O'Neal Comprehensive Cancer Center Birmingham, Alabama, United States
  • Highlands Oncology Group Springdale, Arkansas, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
View all 29 locations
View Trial Details
Recruiting

Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment

NCT05432804

Conditions
Astrocytoma, Glioblastoma, Glioma, +9 more
Locations
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • Keck Medicine of USC Koreatown Los Angeles, California, United States
View all 36 locations
View Trial Details
Recruiting

Mental Health and Suicidality in Glioblastoma Patients in Germany

NCT07409584

Conditions
Astrocytoma, Behavior, Behavioral Symptoms, +14 more
Locations
  • Charite Berlin, Germany
  • University Hospital Knappschaftskrankenhaus Bochum Bochum, Germany
  • University Hospital Essen Essen, Germany
  • University hospital Hamburg Eppendorf Hamburg, Germany
View Trial Details
Recruiting

A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM

NCT05303467

Conditions
Astrocytoma, Glioblastoma, Glioblastoma Multiforme, +9 more
Locations
  • University of Alabama Birmingham Birmingham, Alabama, United States
  • University of California San Diego San Diego, California, United States
  • University of California San Francisco San Francisco, California, United States
  • Mayo Jacksonville Jacksonville, Florida, United States
View Trial Details

Related conditions